These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7002900)

  • 1. In vivo inoculum effect and resistance selection with cefamandole and cefoxitin against Enterobacter cloacae in mice.
    Miller AK; Celozzi E; Pelak BA; Birnbaum J; Stapley EO
    J Antimicrob Chemother; 1980 Nov; 6(6):804-6. PubMed ID: 7002900
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV; Sanders CC; Sanders W
    J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo studies with BL-S786, cefoxitin, and cefamandole.
    Shadomy S; Wagner G; Carver M
    Antimicrob Agents Chemother; 1978 Mar; 13(3):412-5. PubMed ID: 400821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.
    Beckwith DG; Jahre JA
    J Clin Microbiol; 1980 Oct; 12(4):517-20. PubMed ID: 6968320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of R-plasmid mediated beta-lactamase production on the therapeutic efficacy of cefoxitin and cefamandole in experimental chemotherapy.
    Marre R; Schulz E; Freiesleben H
    J Antimicrob Chemother; 1980 Sep; 6(5):633-8. PubMed ID: 6997259
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the efficiency of cefoxitin/cefepime combination against Enterobacteriaceae resistant to expanded-spectrum cephalosporins.
    Serres A; Gibold L; Dalmasso G; Robin F; Bonnet R; Delmas J
    Int J Antimicrob Agents; 2015 Jan; 45(1):86-7. PubMed ID: 25459401
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative in vivo efficiency of cefamandole and cefoxitin against Bacteroides fragilis.
    Bergeron MG; Gauvreau L; Nguyen BM
    Scand J Infect Dis Suppl; 1980; suppl 25():60-5. PubMed ID: 6937954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefamandole in the treatment of infections due to Enterobacter and indole-positive Proteus.
    Levine LR; McCain E
    J Infect Dis; 1978 May; 137 Suppl():S125-S132. PubMed ID: 649997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae.
    Gootz TD; Sanders CC; Goering RV
    J Infect Dis; 1982 Jul; 146(1):34-42. PubMed ID: 6979593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of resistance determinants to cefamandole and cefoxitin in Enterobacter cloacae strains.
    Vuye A
    Microbios; 1983; 38(153-154):159-69. PubMed ID: 6606106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefamandole and cefoxitin.
    Med Lett Drugs Ther; 1979 Feb; 21(3):13-5. PubMed ID: 310945
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistance to cefamandole: a collaborative study of emerging clinical problems.
    Sanders CC; Moellering RC; Martin RR; Perkins RL; Strike DG; Gootz TD; Sanders WE
    J Infect Dis; 1982 Jan; 145(1):118-25. PubMed ID: 6274965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefamandole and cefoxitin.
    Sanders CV; Greenberg RN; Marier RL
    Ann Intern Med; 1985 Jul; 103(1):70-8. PubMed ID: 3890658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of gentamicin-resistant Enterobacteriaceae to cefamandole and cefoxitin.
    Rosenthal SL; Freundlich LF; Quraishi MA
    Chemotherapy; 1979; 25(3):157-61. PubMed ID: 456076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefamandole, cefuroxime and cefoxitin.
    Drug Ther Bull; 1979 Apr; 17(9):35-6. PubMed ID: 446269
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum and tissue concentrations of cefoxitin and cefamandole in women undergoing hysterectomy.
    French MA; Quintiliani R; Nightingale CH; Russo JN
    Obstet Gynecol; 1983 Jan; 61(1):42-7. PubMed ID: 6823348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of second generation cephalosporins: cefamandole, cefoxitine, cefuroxime. Reccomendations by working group].
    Acta Clin Belg; 1980; 35(3):199-201. PubMed ID: 7456969
    [No Abstract]   [Full Text] [Related]  

  • 18. Cefamandole in treatment of peritonitis.
    Stone HH; Guest BS; Geheber CE; Kolb LD
    J Infect Dis; 1978 May; 137 Suppl():S103-S109. PubMed ID: 649995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of carbenicillin and cefamandole by cefoxitin in treatment of experimental infections in mice.
    Goering RV; Sanders CC; Sanders WE
    Antimicrob Agents Chemother; 1982 Jun; 21(6):963-7. PubMed ID: 6921959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost containment of the second-generation cephalosporins by prospective monitoring at a community teaching hospital.
    Williams RR; Gross PA; Levine JF
    Arch Intern Med; 1985 Nov; 145(11):1978-81. PubMed ID: 4062447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.